Home › Funds › DIADEMA PARTNERS LP › MRNA

DIADEMA PARTNERS LP position in MRNA

MODERNA INC · Health Care

DIADEMA PARTNERS LP reported holding 44,400 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$8.6M, representing 2.30% of its reported portfolio and ranking #14 among its reported holdings. DIADEMA PARTNERS LP has disclosed MRNA holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)44.40K sh
Reported value held$8.55M
Portfolio Weight2.30%
First reportedQ1 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How DIADEMA PARTNERS LP's MRNA position evolved

DIADEMA PARTNERS LP first disclosed a stake in MRNA in Q1 2025 at 52,100 shares (US$1.5M). The position peaked in Q3 2026 at 44,400 shares, worth US$8.6M. Across 6 filings, DIADEMA PARTNERS LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 44,400 shares valued at US$8.6M — a reduction of -55,600 shares quarter over quarter.. Notable position changes include a 92% increase in Q2 2025 (shares fell 6% over the following quarter), a 80% trim in Q3 2025 (shares rose 14% over the following quarter), a 56% trim in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 52.10K $1.48M New
Q2 2025 100.00K $2.76M Add
Q3 2025 20.00K $516.60K Reduce
Q1 2026 159.40K $8.10M New
Q2 2026 100.00K $7.00M Reduce
Q3 2026 44.40K $8.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 45 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has DIADEMA PARTNERS LP held MRNA?

DIADEMA PARTNERS LP has disclosed MRNA holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

What is DIADEMA PARTNERS LP's current position in MRNA?

As of Q3 2026, DIADEMA PARTNERS LP holds 44.40K shares of MRNA (MODERNA INC), valued at $8.55M, representing 2.30% of its reported portfolio and ranking #14.

Has DIADEMA PARTNERS LP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), DIADEMA PARTNERS LP reduced its position in MRNA. The position peaked in Q3 2026 at 44.40K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.